SCHEMBL6167893

SCHEMBL6167893

CC1(Cc2ccccc2)NC(=S)N(c2ccc(Oc3ccccc3)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.45
MGLL Q99685 1/20 0.43
LMNA P02545 2/20 0.41
MCHR1 Q99705 4/20 0.40
CNR1 P21554 1/20 0.39
ITGAL P20701 1/20 0.39
MMP2 P08253 3/20 0.37
MMP3 P08254 3/20 0.37
MMP9 P14780 3/20 0.37
MMP13 P45452 3/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
MMP8 P22894 1/20 0.37
NTRK1 P04629 1/20 0.37
IGF1R P08069 1/20 0.37
FGFR1 P11362 1/20 0.37
NTRK3 Q16288 1/20 0.37
NTRK2 Q16620 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13879409 0.79 ITGAL (0.49) ELANEMGLLITGALTSHRALDH1A1
SCHEMBL6167711 0.76 CNR1 (0.50) MGLLLMNACNR1MMP2MMP3
SCHEMBL11569756 0.76 ELANE (0.61) ELANELMNAITGALMAPK1ALDH1A1
SCHEMBL6169639 0.76 CNR1 (0.47) ELANEMGLLLMNACNR1MMP2
SCHEMBL6168870 0.75 GAA (0.46) MGLLLMNACNR1MMP2MMP3
SCHEMBL6169738 0.74 CNR1 (0.43) MGLLLMNACNR1MMP2MMP3
SCHEMBL13879502 0.73 ITGAL (0.61) ELANELMNACNR1ITGALALDH1A1
SCHEMBL6169740 0.72 CNR1 (0.69) MGLLLMNACNR1MMP2MMP3
SCHEMBL1191959 0.72 AR (0.55) MGLLLMNAMMP2MMP3MMP9
SCHEMBL13879421 0.72 ITGAL (0.50) ELANEMGLLMCHR1ITGALALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed